Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.
Press releases published on May 5, 2025
Arialief Side Effects Investigated: Review the User Complaints, Top Benefits & Ingredients List Before Buy!
GlobeNewswire
·
May 5, 2025
ALBANY, N.Y., May 05, 2025 (GLOBE NEWSWIRE) -- If you’re reading this, chances are you, or someone close to you, is dealing with the frustrating, often exhausting symptoms of nerve pain. Whether it’s tingling in your feet, burning sensations in your hands, …
Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.)
GlobeNewswire
·
May 5, 2025
ORION OYJ PÖRSSITIEDOTE / SUURIMMAT OSAKKEENOMISTAJAT -TIEDOTE 5.5.2025 KLO 17.00 Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.) Orion Oyj on saanut Arvopaperimarkkinalain 9. luvun 5 §:n …
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
GlobeNewswire
·
May 5, 2025
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 5 May 2025 at 17:00 EEST Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has …
MicroRNAs Research Initiative in Glioblastoma Stem Cells Awarded $85K by Brain Cancer Canada
GlobeNewswire
·
May 5, 2025
TORONTO, May 05, 2025 (GLOBE NEWSWIRE) -- Brain Cancer Canada is pleased to announce a $85,000 grant for a cutting-edge research initiative led by Dr. Leonardo Salmena at the University of Toronto. The project, titled “Exploring microRNA as Targets for …
Cue Biopharma to Participate in Fireside Chat at the Citizens Life Sciences Conference
GlobeNewswire
·
May 5, 2025
BOSTON, May 05, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of …
CareSource and Lakeland Care, Inc. pursue affiliation to enhance long-term services and supports offerings across Wisconsin
GlobeNewswire
·
May 5, 2025
DAYTON, Ohio and FOND du LAC, Wis., May 05, 2025 (GLOBE NEWSWIRE) -- CareSource, a nationally recognized nonprofit managed care organization, and Lakeland Care, Inc., a leading Wisconsin-based managed care provider, have announced their intent to pursue an …
LainaHealth Launches Clinician + WebAI Care Model to Redefine Physical Therapy Access and Affordability
GlobeNewswire
·
May 5, 2025
Columbus, OH, May 05, 2025 (GLOBE NEWSWIRE) -- LainaHealth, formerly IncludeHealth, announced today the launch of its transformative virtual care model that pairs licensed physical therapists with Laina, a proprietary WebAI assistant, to significantly …
Merit Medical Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY® Arteriovenous Efficacy (WAVE) Trial
GlobeNewswire
·
May 5, 2025
SOUTH JORDAN, Utah, May 05, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced that the 12-month results from the single-arm cohort of the WAVE trial were presented at the annual Charing …
The Wellness Center Health & Therapy Introduces New Neuropathy Program in Fort Worth
GlobeNewswire
·
May 5, 2025
Fort Worth, Texas, May 05, 2025 (GLOBE NEWSWIRE) -- The Wellness Center Health …
Veri Medtech (VRHI) Relaunches DosePop.com
GlobeNewswire
·
May 5, 2025
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Veri Medtech (Stock Ticker Symbol: “VRHI”) announced today the relaunch of its DosePop.com healthcare technology platform. For more information, please visit: www.DosePop.com. “Veri Medtech (VRHI) healthcare …
First Effort to Integrate PacBio HiFi Whole Genome Sequencing in Newborn Screening Launches in Thailand
GlobeNewswire
·
May 5, 2025
MENLO PARK, Calif. and BANGKOK, May 05, 2025 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB) a leading provider of high-quality, highly accurate sequencing platforms, and Chulalongkorn University, a national leader in genomic and translational research, today …
NeurAxis to Host First Quarter 2025 Results and Business Update Call on Monday, May 12, 2025
GlobeNewswire
·
May 5, 2025
CARMEL, Ind., May 05, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults …
Cannabix Technologies Receives NHTSA Approval for BreathLogix Workplace Series Alcohol Breathalyzer
GlobeNewswire
·
May 5, 2025
VANCOUVER, British Columbia, May 05, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) reports that it has received notice from the U.S. National Highway Traffic Safety Association …
Moleculin Bolsters Annamycin Intellectual Property Portfolio with Granting of Two New U.S. Patents
GlobeNewswire
·
May 5, 2025
Company continues to expand global IP coverage and claims to major markets, now extending to June 2040 HOUSTON, May 05, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company …
Gene Therapy Market to Hit US$36.55 Billion by 2032 with 19.4% CAGR | MarketsandMarkets™
GlobeNewswire
·
May 5, 2025
Delray Beach, FL, May 05, 2025 (GLOBE NEWSWIRE) -- The global Gene Therapy market, valued at US$7.21 billion in 2023, is forecasted to grow at a robust CAGR of 19.4%, reaching US$8.85 billion in 2024 and an impressive US$36.55 billion by 2032. Market …
Rose Hill Life Sciences Appoints Biopharma Veteran Jama Pitman as Strategic Advisor
GlobeNewswire
·
May 5, 2025
Seasoned pharmaceutical executive to advise on clinical development, regulatory strategy, and commercialization as Company accelerates its psilocybin-based therapeutic programs BOSTON, May 05, 2025 (GLOBE NEWSWIRE) -- Rose Hill Life Sciences (“The Company” …
Autonomix Highlights Compelling Patient Testimonial Showing Rapid Pain Relief from First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain
GlobeNewswire
·
May 5, 2025
Video testimonial demonstrates pain reduction after transvascular nerve ablation, suggesting potential for improving quality of life in late-stage cancer care Patient testimonial now available here THE WOODLANDS, TX, May 05, 2025 (GLOBE NEWSWIRE) -- …
Rakovina Therapeutics Announces Appointment of Dr. David Kideckel as Chief Financial Officer
GlobeNewswire
·
May 5, 2025
VANCOUVER, British Columbia, May 05, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered …
Ascendis to Share Its Latest Endocrinology Rare Disease Data at ESPE & ESE 2025
GlobeNewswire
·
May 5, 2025
COPENHAGEN, Denmark, May 05, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it will share the latest data from its hypoparathyroidism, achondroplasia, and growth hormone deficiency (GHD) programs during ESPE …
MIMEDX Announces Publication of Health Economics Data in Mohs Micrographic Surgery (MMS)
GlobeNewswire
·
May 5, 2025
MARIETTA, Ga., May 05, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the publication of its health economics data for reconstruction of cutaneous wounds with EPIFIX® (Dehydrated Human Amnion Chorion …